NEW Advanced Electroporation System for Vaccine Development

The New AgilePulse^® In Vivo Electroporation System possesses unique, variable pulse amplitude technology for vaccine delivery or gene therapy applications.

Patented Pulse Agile™ waveforms consist of multiple, low to high voltage pulses with variable pulse lengths, which promotes greater cell membrane poration; resulting in maximum transfection efficiency with minimal damage to the cells or tissues. Gene expression in skin is 100-fold higher¹ when delivery is enhanced by electroporation compared to injection alone.

Features:

• Patented Pulse Agile^® technology
• Resistance measurement for proper needle placement and reproducibility
• Specially designed needle arrays for intra-muscular or intra-dermal applications

Benefits:

• Enhanced immune response¹
• Increased Ag-specific T-cell response¹
• Gene expression is 100-fold higher¹

Visit the BTX website at www.btxonline.com for more information on products, protocols or to view video tutorials for a variety of applications.

To learn more about this exciting new technology or other BTX electroporation or electrofusion products, contact:

These new products are available exclusively through BTX Harvard Apparatus and Harvard Apparatus Distributors, worldwide. For complete specifications on this exciting new DNA Vaccine Delivery System, go to www.btxonline.com or contact the Harvard Apparatus Technical Support Department at techsupport@btxonline.com